U.S. Supreme Court
Jan. 12, 2011
Court Considers Securities Disclosure
The U.S. Supreme Court appeared unswayed Monday by a pharmaceutical company's argument for a fixed, heightened standard on what information drug makers must disclose to avoid a securities fraud lawsuit.
Daily Journal Staff Writer
WASHINGTON - The U.S. Supreme Court appeared unswayed Monday by a pharmaceutical company's argument that the justices should set a heightened standard for what information drug makers must disclose to avoid a securities fraud lawsuit.
But the court signaled a reluctance to open the floodgates by requiring companies to disclose every single report from users claiming side effects from their prod...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In